Skip to main content

Bienville Capital Management, LLC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1605070 New York, NY

Position in RXRX

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$178,222
-$59,214 QoQ
Shares Held
58,053
0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bienville Capital Management, LLC holds $887,164 across 2 Biotechnology names. RXRX ranks #2 (20.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 RXRX
Recursion Pharmaceuticals, Inc.
This page
58,053 $178,222

All Filings in RXRX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $178,222 58,053
2025-12-31 $237,436 58,053
2025-09-30 $283,298 58,053
2025-06-30 $293,748 58,053
2025-03-31 $307,100 58,053
2024-12-31 $392,438 58,053
2024-09-30 $382,569 58,053
2024-06-30 $435,397 58,053
2024-03-31 $578,788 58,053
2023-12-31 $572,402 58,053
2023-09-30 $444,105 58,053
2023-06-30 $424,863 56,876
2023-03-31 $379,362 56,876
2022-12-31 $438,513 56,876
2022-09-30 $648,380 60,938
2022-06-30 $297,622 36,563
2022-03-31 $261,791 36,563
2021-12-31 $626,324 36,563